Cochlioquinone A1, a new anti-angiogenic agent from Bipolaris zeicola

Hye Jin Jung, Hyang Burm Lee, Chi Hwan Lim, Chang Jin Kim, Ho Jeong Kwon

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Cochlioquinone A1 (CoA1) was newly isolated from the culture extract of Bipolaris zeicola as a potent anti-angiogenic agent. CoA1 inhibited in vitro angiogenesis of bovine aortic endothelial cells (BAECs) such as bFGF-induced tube formation and invasion at the concentration (1 μg/mL) without cytotoxicity. Notably, CoA1 exhibited more potent inhibition activity for the growth of BAECs than that of normal and cancer cell lines investigated in this study. These results demonstrate that CoA1 is a new anti-angiogenic agent and can be developed as a new therapeutic agent for angiogenesis-related diseases.

Original languageEnglish
Pages (from-to)4743-4747
Number of pages5
JournalBioorganic and Medicinal Chemistry
Volume11
Issue number22
DOIs
Publication statusPublished - 2003 Nov 1

Fingerprint

Endothelial Cells
Endothelial cells
Cytotoxicity
Cell Line
Growth
Cells
Neoplasms
Therapeutics
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Jung, Hye Jin ; Lee, Hyang Burm ; Lim, Chi Hwan ; Kim, Chang Jin ; Kwon, Ho Jeong. / Cochlioquinone A1, a new anti-angiogenic agent from Bipolaris zeicola. In: Bioorganic and Medicinal Chemistry. 2003 ; Vol. 11, No. 22. pp. 4743-4747.
@article{ab0c1fb3a54e4d3f946f36366d151ac5,
title = "Cochlioquinone A1, a new anti-angiogenic agent from Bipolaris zeicola",
abstract = "Cochlioquinone A1 (CoA1) was newly isolated from the culture extract of Bipolaris zeicola as a potent anti-angiogenic agent. CoA1 inhibited in vitro angiogenesis of bovine aortic endothelial cells (BAECs) such as bFGF-induced tube formation and invasion at the concentration (1 μg/mL) without cytotoxicity. Notably, CoA1 exhibited more potent inhibition activity for the growth of BAECs than that of normal and cancer cell lines investigated in this study. These results demonstrate that CoA1 is a new anti-angiogenic agent and can be developed as a new therapeutic agent for angiogenesis-related diseases.",
author = "Jung, {Hye Jin} and Lee, {Hyang Burm} and Lim, {Chi Hwan} and Kim, {Chang Jin} and Kwon, {Ho Jeong}",
year = "2003",
month = "11",
day = "1",
doi = "10.1016/S0968-0896(03)00523-6",
language = "English",
volume = "11",
pages = "4743--4747",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "22",

}

Cochlioquinone A1, a new anti-angiogenic agent from Bipolaris zeicola. / Jung, Hye Jin; Lee, Hyang Burm; Lim, Chi Hwan; Kim, Chang Jin; Kwon, Ho Jeong.

In: Bioorganic and Medicinal Chemistry, Vol. 11, No. 22, 01.11.2003, p. 4743-4747.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cochlioquinone A1, a new anti-angiogenic agent from Bipolaris zeicola

AU - Jung, Hye Jin

AU - Lee, Hyang Burm

AU - Lim, Chi Hwan

AU - Kim, Chang Jin

AU - Kwon, Ho Jeong

PY - 2003/11/1

Y1 - 2003/11/1

N2 - Cochlioquinone A1 (CoA1) was newly isolated from the culture extract of Bipolaris zeicola as a potent anti-angiogenic agent. CoA1 inhibited in vitro angiogenesis of bovine aortic endothelial cells (BAECs) such as bFGF-induced tube formation and invasion at the concentration (1 μg/mL) without cytotoxicity. Notably, CoA1 exhibited more potent inhibition activity for the growth of BAECs than that of normal and cancer cell lines investigated in this study. These results demonstrate that CoA1 is a new anti-angiogenic agent and can be developed as a new therapeutic agent for angiogenesis-related diseases.

AB - Cochlioquinone A1 (CoA1) was newly isolated from the culture extract of Bipolaris zeicola as a potent anti-angiogenic agent. CoA1 inhibited in vitro angiogenesis of bovine aortic endothelial cells (BAECs) such as bFGF-induced tube formation and invasion at the concentration (1 μg/mL) without cytotoxicity. Notably, CoA1 exhibited more potent inhibition activity for the growth of BAECs than that of normal and cancer cell lines investigated in this study. These results demonstrate that CoA1 is a new anti-angiogenic agent and can be developed as a new therapeutic agent for angiogenesis-related diseases.

UR - http://www.scopus.com/inward/record.url?scp=0141923190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141923190&partnerID=8YFLogxK

U2 - 10.1016/S0968-0896(03)00523-6

DO - 10.1016/S0968-0896(03)00523-6

M3 - Article

C2 - 14556789

AN - SCOPUS:0141923190

VL - 11

SP - 4743

EP - 4747

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 22

ER -